The pharmaceutical industry export market share in Norway has been consistent from 2024 to 2028, maintaining a value of 0.13 each year. This stability indicates no year-on-year variation from 2024 to 2028. As of 2023, the value stood at 0.13, which means there has been no growth or decline up to this point. Over the past two years, the export market share has not experienced any changes. The Compound Annual Growth Rate (CAGR) over the last five years also remains at 0%, signaling a flat trend.

Future trends to watch for include:

Potential regulatory changes that could impact export conditions and market share.
Advancements in pharmaceutical technology and innovation that might open new markets.
Shifts in global healthcare demands, influencing Norway's export dynamics.
Economic conditions affecting the purchasing power and import capacity of Norway's trade partners.